Santhera Pharmaceuticals Holding AG Free Cash Flow Generation Index
Santhera Pharmaceuticals Holding AG free cash flow generation index. Santhera Pharmaceuticals Holding AG (SANN) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of CHF62.54 Million represents 1% of operating cash flow (CHF62.63 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Santhera Pharmaceuticals Holding AG (2019–2023)
Free cash flow generation index of Santhera Pharmaceuticals Holding AG from 2019 to 2023. Historical FCF Generation Index trend for Santhera Pharmaceuticals Holding AG across 2 annual periods. See SANN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Santhera Pharmaceuticals Holding AG Free Cash Flow Generation Index by Year (2019–2023)
Santhera Pharmaceuticals Holding AG free cash flow generation index by year from 2019 to 2023. Year-by-year Free Cash Flow Generation Index for Santhera Pharmaceuticals Holding AG. For the full cash flow conversion analysis, see Santhera Pharmaceuticals Holding AG (SANN) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CHF) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.50x | CHF23.53 Million | CHF47.27 Million | CHF23.74 Million | ▼ -45.4% |
| 2019 | 0.91x | CHF2.37 Million | CHF2.60 Million | CHF229.00K | — |